Deerfield Management Company, L.P. (Series C) Galapagos Nv Transaction History

Deerfield Management Company, L.P. (Series C)

$4.76 Billion
Q2 2024

A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Galapagos Nv stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,411,000 shares of GLPG stock, worth $41.3 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

1,411,000

Previous 1,411,000 -0.0%

Holding current value

$41.3 Million

Previous $45.4 Million 23.04%

% of portfolio

0.73%

Previous 0.94%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$32.2 - $42.44 $25.4 Million - $33.5 Million	788,888 Added 126.81%	1,411,000 $45.4 Million
Q4 2023 Feb 14, 2024	BUY	$31.87 - $40.71 $19.8 Million - $25.3 Million	622,112 New	622,112 $25.3 Million
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $34.3 Million - $46.1 Million	-657,005 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $45.2 Million - $54.8 Million	657,005 New	657,005 $45.3 Million
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $14.8 Million - $21.8 Million	-101,010 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $8.46 Million - $9.79 Million	-75,948 Reduced 42.92%	101,010 $13 Million
Q1 2019 May 15, 2019	SELL	$89.61 - $117.78 $9.99 Million - $13.1 Million	-111,449 Reduced 38.64%	176,958 $20.8 Million
Q4 2018 Feb 14, 2019	BUY	$87.81 - $110.65 $2.49 Million - $3.14 Million	28,343 Added 10.9%	288,407 $26.5 Million
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $8.62 Million - $11.4 Million	95,064 Added 57.61%	260,064 $29.2 Million
Q2 2018 Aug 14, 2018	BUY	$88.4 - $105.34 $3.09 Million - $3.69 Million	35,000 Added 26.92%	165,000 $15.2 Million
Q3 2017 Nov 13, 2017	BUY	$73.17 - $103.47 $9.51 Million - $13.5 Million	130,000	130,000 $13.2 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

17.4M

Call Options Held

10.4K

Put Options Held

33.1K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.93B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account

Deerfield Management Company, L.P. (Series C) Galapagos Nv Transaction History